Prelude Capital Management’s ASP Isotopes ASPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$414K Sell
66,505
-87,145
-57% -$513K 0.03% 612
2026
Q1
$679K Sell
153,650
-74,837
-33% -$443K 0.05% 403
2025
Q4
$1.22M Buy
228,487
+130,091
+132% +$1.03M 0.09% 252
2025
Q3
$947K Sell
98,396
-7,056
-7% -$65.1K 0.07% 316
2025
Q2
$776K Sell
105,452
-48,318
-31% -$324K 0.08% 321
2025
Q1
$721K Buy
153,770
+51,050
+50% +$255K 0.05% 395
2024
Q4
$465K Sell
102,720
-3,608
-3% -$19.2K 0.03% 621
2024
Q3
$296K Buy
+106,328
New +$283K 0.02% 874

Other funds holding ASPI

Prelude Capital Management's ASPI Position: Q2 2026 in Review

Prelude Capital Management reduced its ASP Isotopes (ASPI) stake by 57% in Q2 2026, selling an estimated $513K and leaving 66,505 shares worth $414K. The position accounts for 0.03% of the portfolio, ranked #612.

Prelude Capital Management first reported a position in ASPI in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.22M in Q4 2025. 185 funds tracked by Wall St. Rank hold ASPI as of Q2 2026.

  • Prelude Capital Management held 66,505 shares of ASP Isotopes worth $414K as of Q2 2026.
  • Prelude Capital Management sold 87,145 ASP Isotopes shares in Q2 2026, an estimated $513K.
  • ASP Isotopes made up 0.03% of Prelude Capital Management's portfolio in Q2 2026, its #612 holding.
  • Prelude Capital Management first reported a position in ASP Isotopes in Q3 2024 and has held it in 8 quarters since.
  • Prelude Capital Management's ASP Isotopes position peaked at $1.22M in Q4 2025.
  • 185 funds tracked by Wall St. Rank held ASP Isotopes as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.